It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Mus musculus is the classic mammalian model for biomedical research. Despite global efforts to standardize breeding and experimental procedures, the undefined composition and interindividual diversity of the microbiota of laboratory mice remains a limitation. In an attempt to standardize the gut microbiome in preclinical mouse studies, here we report the development of a simplified mouse microbiota composed of 15 strains from 7 of the 20 most prevalent bacterial families representative of the fecal microbiota of C57BL/6J Specific (and Opportunistic) Pathogen-Free (SPF/SOPF) animals and the derivation of a standardized gnotobiotic mouse model called GM15. GM15 recapitulates extensively the functionalities found in the C57BL/6J SOPF microbiota metagenome, and GM15 animals are phenotypically similar to SOPF or SPF animals in two different facilities. They are also less sensitive to the deleterious effects of post-weaning malnutrition. In this work, we show that the GM15 model provides increased reproducibility and robustness of preclinical studies by limiting the confounding effect of fluctuation in microbiota composition, and offers opportunities for research focused on how the microbiota shapes host physiology in health and disease.
Here, the authors develop and characterize a mouse microbiota composed of 15 strains representative of the intestinal microbiota found in C57BL/6J specific opportunistic- and pathogen-free (C57Bl/6J SOPF) mice and derive a new standardized gnotobiotic mouse model, called GM15, which recapitulates the phenotypes of SOPF or SPF animals in different animal facilities with improved reproducibility.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details








1 Institut de Recherche Technologique, BIOASTER, Lyon, France (GRID:grid.509580.1) (ISNI:0000 0004 4652 9495)
2 Université Claude Bernard Lyon 1, Institut de Génomique Fonctionnelle de Lyon, Université de Lyon, Ecole Normale Supérieure de Lyon, Centre National de la Recherche Scientifique, Lyon, France (GRID:grid.7849.2) (ISNI:0000 0001 2150 7757)
3 Institute of Microbiology of the Czech Academy of Sciences, Laboratory of Gnotobiology, Nový Hrádek, Czech Republic (GRID:grid.418800.5) (ISNI:0000 0004 0555 4846)
4 Ludwig-Maximilians-University of Munich, Max von Pettenkofer Institute of Hygiene and Medical Microbiology, Munich, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X); Partner Site, German Center for Infection Research (DZIF), Munich, Germany (GRID:grid.452463.2)
5 Institut de Recherche Technologique, BIOASTER, Lyon, France (GRID:grid.509580.1) (ISNI:0000 0004 4652 9495); Université Claude Bernard Lyon 1, Institut de Génomique Fonctionnelle de Lyon, Université de Lyon, Ecole Normale Supérieure de Lyon, Centre National de la Recherche Scientifique, Lyon, France (GRID:grid.7849.2) (ISNI:0000 0001 2150 7757)